DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising advancements throughout various medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, a lot more dependable option for therapeutic use,